How a European private equity firm used Nextyn's IDIs and expert network to complete a full commercial due diligence on a MedTech acquisition target — in under two weeks.
The Challenge
A European mid-market private equity firm was evaluating the acquisition of a medical device manufacturer with operations across seven markets. The investment committee required a commercial due diligence report within ten business days.
The firm needed primary intelligence from hospital procurement directors, clinical specialists, distributor networks, and regulatory advisors across multiple geographies — a respondent profile that is notoriously difficult to recruit through standard research channels.
Nextyn's Approach
Nextyn sourced 14 relevant experts from its network of 135,000+ professionals within 48 hours of briefing. The respondent mix included hospital procurement directors, orthopaedic surgeons, medical device distributors, and healthcare regulatory consultants across Germany, France, Spain, Italy, UAE, India, and Singapore.
Each IDI was conducted by a Nextyn healthcare specialist moderator using a structured discussion guide developed in collaboration with the PE firm's deal team. Interviews were conducted remotely over video, recorded with consent, and transcribed in full.
Within 24 hours of the final interview, Nextyn's analysis team delivered a synthesis report covering: competitive positioning and market share validation, pricing dynamics and reimbursement landscape, customer switching costs and loyalty drivers, and regulatory risk assessment across key markets.
The Outcome